| Date Filed | Type | Description |
| 10/06/2023 |
4
| Brownstein Carrie (Chief Medical Officer) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 8,906 shares
@ $19.4265, valued at
$173k
Sold 1,722 shares
@ $19.9102, valued at
$34.3k
|
|
| 10/06/2023 |
4
| Bunker Kevin D. (Chief Scientific Officer) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 5,085 shares
@ $19.4265, valued at
$98.8k
Sold 983 shares
@ $19.9102, valued at
$19.6k
|
|
| 10/06/2023 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 4,594 shares
@ $19.4265, valued at
$89.2k
Sold 888 shares
@ $19.9102, valued at
$17.7k
|
|
| 06/16/2023 |
4
| Johnson David Michael (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 19,059 shares
@ $0 |
|
| 06/16/2023 |
4
| Kariuki Enoch (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 16,364 shares
@ $0 |
|
| 06/16/2023 |
4
| Skvarka Jan (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 16,364 shares
@ $0 |
|
| 05/31/2023 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 9,242 shares
@ $26.3989, valued at
$244k
Sold 18,526 shares
@ $26.2079, valued at
$485.5k
|
|
| 05/31/2023 |
4
| Bunker Kevin D. (Chief Scientific Officer) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 80,000 shares
@ $30.0156, valued at
$2.4M
|
|
| 05/10/2023 |
4
| HAUSMAN DIANA (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 39,732 shares
@ $0 |
|
| 05/10/2023 |
3
| HAUSMAN DIANA (Director) has filed a Form 3 on Zentalis Pharmaceuticals, Inc. |
| 03/02/2023 |
4
| Roth Iris (COO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 52,500 shares
@ $0
Granted 297,500 options to buy
@ $18.87, valued at
$5.6M
|
|
| 02/14/2023 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 2,624 shares
@ $20.4244, valued at
$53.6k
Sold 5,227 shares
@ $19.9753, valued at
$104.4k
|
|
| 02/14/2023 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 3,332 shares
@ $20.4244, valued at
$68.1k
Sold 8,501 shares
@ $19.9631, valued at
$169.7k
|
|
| 02/14/2023 |
4
| Bunker Kevin D. (Chief Scientific Officer) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 3,807 shares
@ $20.4244, valued at
$77.8k
Sold 6,500 shares
@ $19.9805, valued at
$129.9k
|
|
| 02/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/06/2023 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 9,428 shares
@ $22.2213, valued at
$209.5k
Sold 572 shares
@ $23.0351, valued at
$13.2k
|
|
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 12,500 shares
@ $23.5103, valued at
$293.9k
|
|
| 10/07/2022 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 7,004 shares
@ $21.9201, valued at
$153.5k
Sold 5,496 shares
@ $22.8308, valued at
$125.5k
Sold 10,000 shares
@ $22.618, valued at
$226.2k
|
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/16/2022 |
4
| Gallagher Cam (President) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 8,426 shares
@ $25.1029, valued at
$211.5k
Sold 4,074 shares
@ $25.5866, valued at
$104.2k
Sold 8,866 shares
@ $24.3806, valued at
$216.2k
Sold 1,134 shares
@ $24.9898, valued at
$28.3k
|
|
| 09/12/2022 |
4
| Skvarka Jan (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 36,606 shares
@ $0 |
|
|